Literature DB >> 35546306

A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1.

Andrew J D Crow1, Jennica M Janssen1,2, Carolina Marshall1,3, Anne Moffit1,4, Laura Brennan5, Christian G Kohler1,6, David R Roalf1,6, Paul J Moberg1.   

Abstract

Neurofibromatosis Type 1 (NF1) is a common genetic disorder frequently associated with cognitive deficits. Despite cognitive deficits being a key feature of NF1, the profile of such impairments in NF1 has been shown to be heterogeneous. Thus, we sought to quantitatively synthesize the extant literature on cognitive functioning in NF1. A random-effects meta-analysis of cross-sectional studies was carried out comparing cognitive functioning of patients with NF1 to typically developing or unaffected sibling comparison subjects of all ages. Analyses included 50 articles (Total NNF1 = 1,522; MAge = 15.70 years, range = 0.52-69.60), yielding 460 effect sizes. Overall moderate deficits were observed [g = -0.64, 95% CI = (-0.69, -0.60)] wherein impairments differed at the level of cognitive domain. Deficits ranged from large [general intelligence: g = -0.95, 95% CI = (-1.12, -0.79)] to small [emotion: g = -0.37, 95% CI = (-0.63, -0.11)]. Moderation analyses revealed nonsignificant contributions of age, sex, educational attainment, and parental level of education to outcomes. These results illustrate that cognitive impairments are diffuse and salient across the lifespan in NF1. Taken together, these results further demonstrate efforts should be made to evaluate and address cognitive morbidity in patients with NF1 in conjunction with existing best practices.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  NF1; academic; clinical assessment; cognitive; intelligence; research synthesis

Mesh:

Year:  2022        PMID: 35546306      PMCID: PMC9302478          DOI: 10.1002/ajmg.a.62773

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.578


  93 in total

1.  Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.

Authors:  Robert S Greenwood; Larry A Tupler; J Kenneth Whitt; Anne Buu; Carrie B Dombeck; Amanda G Harp; Martha E Payne; James D Eastwood; K Ranga R Krishnan; James R MacFall
Journal:  Arch Neurol       Date:  2005-12

2.  Paternal origin of new mutations in von Recklinghausen neurofibromatosis.

Authors:  D Jadayel; P Fain; M Upadhyaya; M A Ponder; S M Huson; J Carey; A Fryer; C G Mathew; D F Barker; B A Ponder
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

3.  Facial emotion recognition, face scan paths, and face perception in children with neurofibromatosis type 1.

Authors:  Amelia K Lewis; Melanie A Porter; Tracey A Williams; Samantha Bzishvili; Kathryn N North; Jonathan M Payne
Journal:  Neuropsychology       Date:  2017-03-20       Impact factor: 3.295

4.  Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status.

Authors:  B D Moore; J M Slopis; E F Jackson; A E De Winter; N E Leeds
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

5.  Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.

Authors:  Jacquelyn A Brown; Ryan J Emnett; Crystal R White; Carla M Yuede; Sara B Conyers; Karen L O'Malley; David F Wozniak; David H Gutmann
Journal:  Hum Mol Genet       Date:  2010-09-07       Impact factor: 6.150

6.  Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.

Authors:  M-J Descheemaeker; E Plasschaert; J-P Frijns; E Legius
Journal:  J Intellect Disabil Res       Date:  2012-10-24

7.  Is there a relationship between executive functions and academic success in children with neurofibromatosis type 1?

Authors:  Yafit Gilboa; Sara Rosenblum; Aviva Fattal-Valevski; Hagit Toledano-Alhadef; Naomi Josman
Journal:  Neuropsychol Rehabil       Date:  2014-05-30       Impact factor: 2.868

8.  Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)?

Authors:  Cinzia Galasso; Adriana Lo-Castro; Loredana Di Carlo; Maria Bernarda Pitzianti; Elisa D'Agati; Paolo Curatolo; Augusto Pasini
Journal:  J Child Neurol       Date:  2014-02-13       Impact factor: 1.987

Review 9.  Neurofibromatosis type 1 revisited.

Authors:  Virginia C Williams; John Lucas; Michael A Babcock; David H Gutmann; Bruce Korf; Bernard L Maria
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

10.  Attention and Motor Learning in Adult Patients with Neurofibromatosis Type 1.

Authors:  Jesminne Castricum; Joke H M Tulen; Walter Taal; André B Rietman; Ype Elgersma
Journal:  J Atten Disord       Date:  2021-05-12       Impact factor: 3.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.